Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later. (Q30354814)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Matthew D Snape

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

8

object named as

Maria Zambon

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Elizabeth Miller

9

object named as

Elizabeth Miller

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

5

object named as

Andrew J Pollard

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Nick J. Andrews

2

object named as

Nick J Andrews

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Katja Hoschler

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Adam Finn

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Woolf T Walker

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

0 references

publication date

22 October 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Clinical Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

58

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

181-187

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Original antigenic sin responses to influenza viruses

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Comparison of influenza serological techniques by international collaborative study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Immunogenicity and Reactogenicity of 1 versus 2 Doses of Trivalent Inactivated Influenza Vaccine in Vaccine‐Naive 5–8‐Year‐Old Children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT692

21 January 2018

Identifiers

10.1093/CID/CIT692

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24149079%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30354814&oldid=1907884083"